TROXACITABINE structure, CAS 145918-75-8

TROXACITABINE

CAS Number145918-75-8

SynonymsS1535_Selleck; Bch-4556; cis-Dioxolane-C; Troxacitabine

Molecular FormulaC8H11N3O4

Molecular Weight213.19100

Purity

Density1.71g/cm3

Boiling Point422.5ºC at 760mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1170516 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 145918-75-8 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number145918-75-8
Catalog No.2A-1170516
Chinese Name4-氨基-1-[(2S)-2-(羟甲基)-1,3-二氧杂环戊-4-基]嘧啶-2-酮
SynonymsS1535_Selleck; Bch-4556; cis-Dioxolane-C; Troxacitabine
Molecular FormulaC8H11N3O4
Molecular Weight213.19100
Density1.71g/cm3
Boiling Point422.5ºC at 760mmHg
ApplicationTroxacitabine is a dioxolane analogue with potent antitumor activity.
HTC2933599090
SMILESNc1ccn(C2COC(CO)O2)c(=O)n1
InChIInChI=1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6?,7-/m0/s1
InChI KeyRXRGZNYSEHTMHC-MLWJPKLSSA-N
Use ofTroxacitabine is nucleoside analog with potent anticancer activity. Properties Name 4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one Synonym More Synonyms Troxacitabine Biological Activity Description Troxacitabine is nucleoside analog with potent anticancer activity. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Cancer In Vitro Troxacitabine has shown cutotoxicity in cancer cell lines of hepatocellular (HepG2), prostate (PC3, DUI45), non-small cell lung (NCI-H460, NCr-322M) colon (HT29), renal (CAK-l, A498, RXF-393, SNI2-C) and pancreatic origin (Pnac-Ol, MiaPa Ca) with IC50s range from 15-35 μM[1][2]. References [1]. Gourdeau H, et al. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Cancer Chemother Pharmacol. 2002 Dec;50(6):490-6. [2]. Kadhim SA, et al. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models. Cancer Res. 1997 Nov 1;57(21):4803-10. [3]. Weitman S, et al. The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity againstpancreatic human tumor xenografts. Clin Cancer Res. 2000 Apr;6(4):1574-8. Chemical & Physical Properties Molecular Formula C8H11N3O4 Exact Mass 213.07500 PSA 99.60000 Index of Refraction 1.694 InChIKey RXRGZNYSEHTMHC-MLWJPKLSSA-N Safety Information HS Code 2933599090 Synthetic Route CAS#:146996-25-0 Troxacitabine CAS#:145918-75-8 Literature: Kim; Schinazi; Shanmuganathan; Jeong; Beach; Nampalli; Cannon; Chu Journal of Medicinal Chemistry, 1993 , vol. 36, # 5 p. 519 - 528 Benzoic acid (2... CAS#:145414-63-7 Troxacitabine CAS#:145918-75-8 Literature: Tetrahedron Letters, , vol. 33, # 46 p. 6899 - 6902 [(2S)-4-(acetyl... CAS#:145875-99-6 Troxacitabine CAS#:145918-75-8 (-)-L-α-dioxola... CAS#:145416-37-1 Literature: Tetrahedron Letters, , vol. 33, # 46 p. 6949 - 6952
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Related Products in Specialty Chemicals
(2,6-DIMETHYLPHENOXY)-ACETYLCHLORIDE20143-48-02A-1170506
cis-5,6,7,8-tetrahydronaphthalene-1,6,7-triol35697-16-62A-1170508
cis-3a,4,9,9a-tetrahydro-2,2-dimethylnaphtho[2,3-d]-1,3-dioxol-5-ol52187-19-62A-1170509
2-Bromo-5-fluoro-3-methylaniline1463053-93-12A-1170512
daprodustat,GSK1278863960539-70-22A-1170515
BMS 564929627530-84-12A-1170517
14-Bromo Daunorubicin Hydrobromide Salt 60873-68-92A-1170518
FLUO 3134907-84-92A-1170520
heptadecafluoro-N-methyloctanesulphonamide31506-32-82A-1170522
CYCLOPENTA(C,D)PYRENE27208-37-32A-1170523
Browse all Specialty Chemicals products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA